Jo‐Anne H. van Burik

3.4k total citations
24 papers, 1.9k citations indexed

About

Jo‐Anne H. van Burik is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Jo‐Anne H. van Burik has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Infectious Diseases and 10 papers in Oncology. Recurrent topics in Jo‐Anne H. van Burik's work include Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (10 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Jo‐Anne H. van Burik is often cited by papers focused on Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (10 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Jo‐Anne H. van Burik collaborates with scholars based in United States, South Africa and Germany. Jo‐Anne H. van Burik's co-authors include Daniel J. Weisdorf, Raleigh A. Bowden, Paul T. Magee, John E. Wagner, Todd E. DeFor, Kieren A. Marr, David H. Spach, Roy Colven, David C. Dale and Juliet N. Barker and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Jo‐Anne H. van Burik

24 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo‐Anne H. van Burik United States 19 1.1k 930 473 422 211 24 1.9k
J Tollemar Sweden 30 1.7k 1.6× 1.7k 1.8× 463 1.0× 318 0.8× 132 0.6× 87 3.1k
Anne Thiébaut France 21 1.4k 1.3× 1.4k 1.5× 436 0.9× 378 0.9× 78 0.4× 42 2.1k
Pietro Martino Italy 22 1.3k 1.2× 1.3k 1.4× 789 1.7× 126 0.3× 219 1.0× 42 2.3k
Zdeněk Ráčil Czechia 20 762 0.7× 868 0.9× 245 0.5× 547 1.3× 158 0.7× 81 1.7k
John W. Hiemenz United States 14 1.3k 1.2× 1.4k 1.5× 322 0.7× 147 0.3× 79 0.4× 28 2.0k
Sabine Mousset Germany 19 638 0.6× 532 0.6× 325 0.7× 122 0.3× 68 0.3× 39 1.3k
Nikolaos G. Almyroudis United States 21 1.0k 0.9× 1.1k 1.1× 310 0.7× 100 0.2× 77 0.4× 35 1.7k
Fulvio Crippa Italy 8 1.4k 1.2× 1.4k 1.5× 391 0.8× 97 0.2× 132 0.6× 15 1.8k
Angelika Böhme Germany 23 1.2k 1.1× 1.3k 1.4× 617 1.3× 85 0.2× 138 0.7× 59 1.8k
T. J. Walsh United States 18 1.0k 0.9× 1.1k 1.2× 246 0.5× 42 0.1× 208 1.0× 23 1.7k

Countries citing papers authored by Jo‐Anne H. van Burik

Since Specialization
Citations

This map shows the geographic impact of Jo‐Anne H. van Burik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo‐Anne H. van Burik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo‐Anne H. van Burik more than expected).

Fields of papers citing papers by Jo‐Anne H. van Burik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo‐Anne H. van Burik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo‐Anne H. van Burik. The network helps show where Jo‐Anne H. van Burik may publish in the future.

Co-authorship network of co-authors of Jo‐Anne H. van Burik

This figure shows the co-authorship network connecting the top 25 collaborators of Jo‐Anne H. van Burik. A scholar is included among the top collaborators of Jo‐Anne H. van Burik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo‐Anne H. van Burik. Jo‐Anne H. van Burik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patnaik, Mrinal M., Dale E. Hammerschmidt, Jo‐Anne H. van Burik, José Jessurun, & P. P. A. Smyth. (2008). Lepromatous leprosy masquerading as acute sarcoidosis: a case report and literature review.. PubMed. 91(11). 30–3. 4 indexed citations
2.
3.
Foy, Patrick, Jo‐Anne H. van Burik, & Daniel J. Weisdorf. (2007). Galactomannan Antigen Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 13(4). 440–443. 26 indexed citations
4.
Walker, Christopher M., et al.. (2007). Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources. Biology of Blood and Marrow Transplantation. 13(9). 1106–1115. 80 indexed citations
5.
Copelan, Edward A., James T. Casper, Shelly L. Carter, et al.. (2007). A Scheme for Defining Cause of Death and Its Application in the T Cell Depletion Trial. Biology of Blood and Marrow Transplantation. 13(12). 1469–1476. 100 indexed citations
6.
Burik, Jo‐Anne H. van. (2006). Yüksek risk taşıyan hastalarda mikozların profilaksisinde yeni antifungal ilaçların rolü. Current Opinion in Infectious Diseases. 1(1). 1–7. 2 indexed citations
7.
Denning, David W., Kieren A. Marr, W. Lau, et al.. (2006). Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. Journal of Infection. 53(5). 337–349. 209 indexed citations
8.
Cornely, Oliver A., Andrew J. Ullmann, Meinolf Karthaus, Thomas J. Walsh, & Jo‐Anne H. van Burik. (2005). Choosing a study population for the evaluation of antifungal prophylaxis. Author's reply. Clinical Infectious Diseases. 40(11). 1699–1701. 1 indexed citations
9.
Derkay, Craig S., Richard J. Smith, John E. McClay, et al.. (2005). HspE7 Treatment of Pediatric Recurrent Respiratory Papillomatosis: Final Results of an Open-Label Trial. Annals of Otology Rhinology & Laryngology. 114(9). 730–737. 63 indexed citations
10.
Burik, Jo‐Anne H. van. (2005). Role of new antifungal agents in prophylaxis of mycoses in high risk patients. Current Opinion in Infectious Diseases. 18(6). 479–483. 25 indexed citations
11.
Barker, Juliet N., Rachael Hough, Jo‐Anne H. van Burik, et al.. (2005). Serious Infections after Unrelated Donor Transplantation in 136 Children: Impact of Stem Cell Source. Biology of Blood and Marrow Transplantation. 11(5). 362–370. 99 indexed citations
12.
Holman, Carol, Jo‐Anne H. van Burik, Steven H. Hinrichs, & Henry H. Balfour. (2003). Specific Detection of Human BK Polyomavirus in Urine Samples of Immunocompromised Patients. Clinical and Vaccine Immunology. 10(1). 66–69. 10 indexed citations
13.
Burik, Jo‐Anne H. van, et al.. (2001). Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. Biology of Blood and Marrow Transplantation. 7(12). 674–679. 36 indexed citations
14.
Burik, Jo‐Anne H. van, et al.. (1999). Modulation of Neutrophil‐Mediated Activity Against the Pseudohyphal Form ofCandida albicansby Granulocyte Colony‐Stimulating Factor (G‐CSF) Administered In Vivo. The Journal of Infectious Diseases. 179(5). 1301–1304. 30 indexed citations
15.
Burik, Jo‐Anne H. van & Daniel J. Weisdorf. (1999). INFECTIONS IN RECIPIENTS OF BLOOD AND MARROW TRANSPLANTATION. Hematology/Oncology Clinics of North America. 13(5). 1065–1089. 32 indexed citations
16.
17.
Burik, Jo‐Anne H. van, Roy Colven, & David H. Spach. (1998). Itraconazole Therapy for Primary Cutaneous Aspergillosis in Patients with AIDS. Clinical Infectious Diseases. 27(3). 643–644. 11 indexed citations
18.
19.
Liles, W. Conrad, Jane E. Huang, Jo‐Anne H. van Burik, Raleigh A. Bowden, & David C. Dale. (1997). Granulocyte Colony‐Stimulating Factor Administered In Vivo Augments Neutrophil‐Mediated Activity against Opportunistic Fungal Pathogens. The Journal of Infectious Diseases. 175(4). 1012–1015. 106 indexed citations
20.
Marr, Kieren A., Theodore C. White, Jo‐Anne H. van Burik, & Raleigh A. Bowden. (1997). Development of Fluconazole Resistance inCandida albicansCausing Disseminated Infection in a Patient Undergoing Marrow Transplantation. Clinical Infectious Diseases. 25(4). 908–910. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Tollemar Breakdown of academic impact, for papers by Anne Thiébaut Breakdown of academic impact, for papers by Pietro Martino Breakdown of academic impact, for papers by Zdeněk Ráčil Breakdown of academic impact, for papers by John W. Hiemenz Breakdown of academic impact, for papers by Sabine Mousset Breakdown of academic impact, for papers by Nikolaos G. Almyroudis Breakdown of academic impact, for papers by Fulvio Crippa Breakdown of academic impact, for papers by Angelika Böhme Breakdown of academic impact, for papers by T. J. Walsh
Rankless by CCL
2026